Dr. Rice on the Importance of Clinical Trials in Gynecologic Cancer

Laurel W. Rice, MD
Published: Wednesday, Apr 11, 2018



Laurel W. Rice, MD, chair, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, discusses the importance of enrolling patients with gynecologic cancer on clinical trials.

Without the ability for patients to enroll on clinical trials, patient care diminishes. In general, access to care is often caused by health disparities, says Rice. There are a variety of patients in the United States who do not have access to healthcare for many reasons, including insurance status or where they live, Rice adds. The workforce issues in healthcare continue to be worrisome.
 


Laurel W. Rice, MD, chair, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, discusses the importance of enrolling patients with gynecologic cancer on clinical trials.

Without the ability for patients to enroll on clinical trials, patient care diminishes. In general, access to care is often caused by health disparities, says Rice. There are a variety of patients in the United States who do not have access to healthcare for many reasons, including insurance status or where they live, Rice adds. The workforce issues in healthcare continue to be worrisome.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x